My research focuses on improving outcomes for patients with traumatic injury or critical illness. My team studies how to prevent dangerous blood clots in these patients as well as how to better recognize and manage life-threatening bleeding. The three main programs—PrOVE-iT, PrOVE-ICU, and CAN-BLEED— aim to design and validate novel risk scores, which we in turn incorporate into innovative clinical trials that match treatment decisions to the individual needs of each patient based on those personalized risk assessments. These studies also prioritize diversity, patient input, and pragmatic health interventions to improve care for injured and critically ill patients across Canada.